Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

FluoroquinoloneMycobacterium

Interventions

DRUG

Sitafloxacin

Study medication: Sitafloxacin 100mg QD for 14 days.

Trial Locations (1)

Beijing chest hospital affiliated to Capital medical university, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing

All Listed Sponsors

lead

Beijing Chest Hospital

OTHER